Arda Karaduman is appointed as CEO of ELAA Technology to develop and execute its global growth strategy

ELAA Technology,a digital health company developing solutions for cancer early diagnosis, announces the appointment of Arda Karaduman as Chief Executive Officer as from May, 2020.

“Since its inception in 2017 , ELAA Technology has made great progress in commercializing its Pure Digital Medical Navigation Platform technology and its lead product PRECIMON™ for lung cancer early diagnosis. We have had the privilege working with Mr.Arda Karaduman as our lead mentor thanks to HIT acceleration program run by Technology Development Foundation of Turkey (TTGV) . As a team we’ve had a big leap forward and in April 2020, we received ISO 13485:2016 certification for ELAA Technology and CE cerfitification for PRECIMON™. Now it is time to scale up and we reached Mr.Arda Karaduman to work with him growing ELAA Technology bigger globally, thinking of his past commercialization and business development experience . I am glad that he accepted to join our journey and glad to have him onboard.” Said Dr.Tunç Laçin, Co-Founder and Chairman of ELAA Technology.

“I am very excited to join ELAA Technology team and pretty much sure that you will hear from us more in very near future thanks to this great team onboard. We are planning to develop new strategies for growth markets and execute rapidly as well as keeping our focus on bringing in more products to the market. “ commented Mr. Arda Karaduman, Chief Executive Officer of ELAA Technology

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.    OK   Learn More